Search bioRxiv⌕ Search

Biology subjects

Gorman, K.

Publications and source records attributed to Gorman, K..

2 recordsLinked to original sources

Spatiotemporally organized immunomodulatory response to SARS-CoV-2 virus in primary human broncho-alveolar epithelia

The COVID-19 pandemic continues to be a health crisis with major unmet medical needs. The early responses from airway epithelial cells, the first target of the virus regulating the progression towards severe disease, are not fully understood. Primary human air-liquid interface cultures representing the broncho-alveolar epithelia were used to study the kinetics and dynamics of SARS-CoV-2 variants infection. The infection measured by nucleoprotein expression, was a late event appearing between day 4-6 post infection for Wuhan-like virus. Other variants demonstrated increasingly accelerated timelines of infection. All variants triggered similar transcriptional signatures, an "early" inflammatory/immune signature preceding a "late" type I/III IFN, but differences in the quality and kinetics were found, consistent with the timing of nucleoprotein expression. Response to virus was spatially organized: CSF3 expression in basal cells and CCL20 in apical cells. Thus, SARS-CoV-2 virus triggers specific responses modulated over time to engage different arms of immune response.

immunology↗

Assessing risks and mechanisms of idiosyncratic drug toxicity by fingerprints of cell signaling responses.

Idiosyncratic drug-induced liver injury (DILI) is the leading cause of post-marketing drug withdrawal. Here, we describe a straightforward DILI liability assessment approach based on fingerprinting cell signaling responses. The readout is the activity of transcription factors (TF) that link signaling pathways to genes. Using a multiplex reporter assay for 45 TFs in hepatocytic cells, we assessed TF activity profiles (TFAP) for 13 pharmacological classes. The TFAP signatures were consistent with primary drug activity but transformed into different, off-target signatures at certain concentrations (COFF). We show that the off-target signatures pertained to DILI-relevant mechanisms, including mitochondria malfunction, proteotoxicity, and lipid peroxidation. Based on reported plasma concentrations in humans (CMAX), drugs do not reach the off-target thresholds in vivo, consistent with the lack of overt toxicity in the population. However, DILI liability drugs were dangerously close to the off-target thresholds. We characterized this closeness by the COFF/CMAX ratio termed the safety margin (SM). Most-DILI-concern drugs invariably showed smaller safety margins than their less-concern counterparts in each pharmacological class and across classes (median SM values of 6.4 and 212.7, respectively (P<0.00015)). Therefore, the TFAP approach helps to explain idiosyncratic drug toxicity and provides clear quantitative metrics for its probability and the underlying mechanisms.

pharmacology and toxicology↗